Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus - Infected patients

Journal of Infectious Diseases

Volumn 177, Issue 4, 1998, Pages 1080-1083

  Tural, C ^a   Romeu, J ^a   Sirera, G ^a   Andreu, D ^a   Conejero, M ^a   Ruiz, S ^a   Jou, A ^a   Bonjoch, A ^a   Ruiz, L ^a   Arno A ^a   Clotet, B ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; FOSCARNET; GANCICLOVIR; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; BACTEREMIA; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CYTOMEGALOVIRUS; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MALE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION; RETINITIS;

EID: 17344373825     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517399     Document Type: Article

References (15)

1. Pertel P, Hirschtick R, Phari J, Chmiel J, Poggense L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992;5:1069-74.
2. Drew WL, Ives D, Lalezari JP, et al. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med 1995;333:615-20.
3. Jacobson MA, Kramer F, Bassiakos Y, et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical trials group protocol 151. J Infect Dis 1994;170:189-93.
4. Hansen KK, Richsten A, Hofmann B, Norrild B, Olofsson F, Mahiessen L. Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS. J Infect Dis 1994;170:1271-4.
5. Spector SA, Merrill R, Wolf D, Danker WM. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol 1992;30:2359-65.
6. Shinkai M, Bozzette SA, Powderly W, Frame P, Spector SA. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J Infect Dis 1997;175:302-8.
7. Bowen EF, Wilson P, Cope A, et al. Cytomegalovirus retinitis in AIDS patients. Influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS 1996;10:1515-20.
8. Dodt KK, Jacobsen PH, Hofmann B, et al. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test AIDS 1997;11:F21-8.
9. Cameron B, Heath-Chiozzi M, Kravick S, Mills R, Pothoff A, Henry D. Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir [abstract LB6a]. In: Program and abstracts: 3rd Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1996.
10. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.
11. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. recommendations of an international panel. JAMA 1996;276:146-54.
12. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997;3:533-9.
13. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-6.
14. Whitcup SM, Fortin E, Nussenblatt RB, Polis MA, Muccioli C. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis [letter]. JAMA 1997;227:1519-20.
15. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-5.